{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:48:22Z","timestamp":1790682502248,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1111\/jth.15487","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T15:22:47Z","timestamp":1628349767000},"page":"2659-2673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Venous thromboembolism associated with central venous catheters in patients with cancer: From pathophysiology to thromboprophylaxis, areas for future studies"],"prefix":"10.1016","volume":"19","author":[{"given":"Philippe","family":"Debourdeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9odore","family":"Debourdeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Yves","family":"Marcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-316X","authenticated-orcid":false,"given":"L\u00e9a","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1111\/jth.15487_bb0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jvir.2017.12.009","article-title":"Chronic central venous access: from research consensus panel to national multistakeholder initiative","volume":"29","author":"Baskin","year":"2018","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"10.1111\/jth.15487_bb0015","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMra011883","article-title":"Preventing complications of central venous catheterization","volume":"348","author":"McGee","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1111\/jth.15487_bb0020","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bjh.12474","article-title":"Catheter\u2010related thrombosis in cancer patients","volume":"162","author":"Murray","year":"2013","journal-title":"Br J Haematol"},{"issue":"19","key":"10.1111\/jth.15487_bb0025","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2003.08.008","article-title":"Venous thromboembolism associated with long\u2010term use of central venous catheters in cancer patients","volume":"21","author":"Verso","year":"2003","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1111\/jth.15487_bb0030","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1186\/s12885-018-5213-9","article-title":"Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score\u2010matched analysis","volume":"18","author":"Liang","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1111\/jth.15487_bb0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.amjsurg.2013.08.046","article-title":"Line\u2010associated thrombosis as the major cause of hospital\u2010acquired deep vein thromboses: an analysis from National Surgical Quality Improvement Program data and a call to reassess prophylaxis strategies","volume":"208","author":"Mino","year":"2014","journal-title":"Am J Surg"},{"issue":"5","key":"10.1111\/jth.15487_bb0040","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/jth.12527","article-title":"Catheter\u2010associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH","volume":"12","author":"Zwicker","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1111\/jth.15487_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jth.12071","article-title":"International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer","volume":"11","author":"Debourdeau","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"Suppl 5","key":"10.1111\/jth.15487_bb0050","doi-asserted-by":"crossref","first-page":"v152","DOI":"10.1093\/annonc\/mdv296","article-title":"Central venous access in oncology: ESMO clinical practice guidelines","volume":"26","author":"Sousa","year":"2015","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1111\/jth.15487_bb0055","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.thromres.2014.06.011","article-title":"Follow\u2010up after four\u2010year quality improvement program to prevent inferior limb deep vein thrombosis in intensive care unit","volume":"134","author":"Boddi","year":"2014","journal-title":"Thromb Res"},{"issue":"4","key":"10.1111\/jth.15487_bb0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1378\/chest.10-0154","article-title":"Risk of symptomatic DVT associated with peripherally inserted central catheters","volume":"138","author":"Evans","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1111\/jth.15487_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jvir.2013.10.009","article-title":"Peripherally inserted central catheter thrombosis\u2010\u2010reverse tapered versus nontapered catheters: a randomized controlled study","volume":"25","author":"Itkin","year":"2014","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"10.1111\/jth.15487_bb0070","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/annonc\/mdp235","article-title":"Early and short\u2010term acenocumarine or dalteparin for the prevention of central vein catheter\u2010related thrombosis in cancer patients: a randomized controlled study based on serial venographies","volume":"20","author":"De Cicco","year":"2009","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1111\/jth.15487_bb0075","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/imj.14780","article-title":"Catheter\u2010related thrombosis incidence and risk factors in adult cancer patients with central venous access devices","volume":"50","author":"Ellis","year":"2020","journal-title":"Intern Med J"},{"issue":"7","key":"10.1111\/jth.15487_bb0080","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1182\/blood-2018-03-837153","article-title":"Cancer\u2010associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP)","volume":"132","author":"Decousus","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1111\/jth.15487_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(97)00054-6","article-title":"Central venous thrombosis: an early and frequent complication in cancer patients bearing long\u2010term silastic catheter. A prospective study","volume":"86","author":"De Cicco","year":"1997","journal-title":"Thromb Res"},{"issue":"4","key":"10.1111\/jth.15487_bb0090","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1538-7836.2010.03771.x","article-title":"Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review","volume":"8","author":"Di Nisio","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1111\/jth.15487_bb0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archinte.162.4.401","article-title":"Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review","volume":"162","author":"Mustafa","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1111\/jth.15487_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archinte.1997.00440220061008","article-title":"Upper\u2010extremity deep vein thrombosis. Risk factors, diagnosis, and complications","volume":"157","author":"Prandoni","year":"1997","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1111\/jth.15487_bb0105","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1148\/radiology.211.2.r99ma08579","article-title":"Subclavian and internal jugular veins at Doppler US: abnormal cardiac pulsatility and respiratory phasicity as a predictor of complete central occlusion","volume":"211","author":"Patel","year":"1999","journal-title":"Radiology"},{"issue":"7\u20138","key":"10.1111\/jth.15487_bb0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.diii.2012.03.025","article-title":"Radio\u2010anatomy of the superior vena cava syndrome and therapeutic orientations","volume":"93","author":"Lacout","year":"2012","journal-title":"Diagn Interv Imaging"},{"issue":"5","key":"10.1111\/jth.15487_bb0115","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2214\/ajr.172.5.10227511","article-title":"Helical CT phlebography of the superior vena cava: diagnosis and evaluation of venous obstruction","volume":"172","author":"Qanadli","year":"1999","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1111\/jth.15487_bb0120","first-page":"70","article-title":"Superior vena cava syndrome: do not miss the Ariadne's thread","volume":"19","author":"El Hajjam","year":"2013","journal-title":"Diagn Interv Radiol"},{"issue":"6","key":"10.1111\/jth.15487_bb0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial","volume":"112","author":"Bern","year":"1990","journal-title":"Ann Intern Med"},{"issue":"1158","key":"10.1111\/jth.15487_bb0130","first-page":"U105","article-title":"Outpatient treatment of community acquired venous thromboembolism\u2013the Christchurch experience","volume":"115","author":"Heaton","year":"2002","journal-title":"N Z Med J"},{"issue":"18","key":"10.1111\/jth.15487_bb0135","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1200\/JCO.2005.10.192","article-title":"Randomized placebo\u2010controlled study of low\u2010dose warfarin for the prevention of central venous catheter\u2010associated thrombosis in patients with cancer","volume":"23","author":"Couban","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1111\/jth.15487_bb0140","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/08035250600729092","article-title":"Low\u2010dose warfarin for the prevention of central line\u2010associated thromboses in children with malignancies\u2013a randomized, controlled study","volume":"95","author":"Ruud","year":"2006","journal-title":"Acta Paediatr"},{"issue":"9663","key":"10.1111\/jth.15487_bb0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(09)60205-1","article-title":"Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open\u2010label randomised trial","volume":"373","author":"Young","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1111\/jth.15487_bb0150","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","article-title":"Upper extremity deep venous thrombosis in cancer patients with venous access devices\u2013prophylaxis with a low molecular weight heparin (Fragmin)","volume":"75","author":"Monreal","year":"1996","journal-title":"Thromb Haemost"},{"issue":"18","key":"10.1111\/jth.15487_bb0155","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","article-title":"Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double\u2010blind, placebo\u2010controlled, randomized study in cancer patients","volume":"23","author":"Verso","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1111\/jth.15487_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/annonc\/mdj059","article-title":"Dalteparin for prevention of catheter\u2010related complications in cancer patients with central venous catheters: final results of a double\u2010blind, placebo\u2010controlled phase III trial","volume":"17","author":"Karthaus","year":"2006","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1111\/jth.15487_bb0165","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/j.1538-7836.2007.02660.x","article-title":"Prevention of catheter\u2010related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo\u2010controlled study","volume":"5","author":"Niers","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1111\/jth.15487_bb0170","first-page":"654","article-title":"Ben Abdeladhim, prevention of central venous line\u2010related thrombosis by continuous infusion of low\u2010dose unfractionated heparin, in patients with haemato\u2010oncological disease. A randomized controlled trial","volume":"92","author":"Abdelkefi","year":"2004","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1111\/jth.15487_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00280-013-2169-y","article-title":"Prophylaxis of catheter\u2010related deep vein thrombosis in cancer patients with low\u2010dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study","volume":"72","author":"Lavau\u2010Denes","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12","key":"10.1111\/jth.15487_bb0180","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1111\/j.1538-7836.2007.02751.x","article-title":"Thromboprophylaxis for catheter\u2010related thrombosis in patients with cancer: a systematic review of the randomized, controlled trials","volume":"5","author":"Carrier","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1111\/jth.15487_bb0185","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1188\/07.ONF.1037-1043","article-title":"The use of low\u2010dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: a meta\u2010analysis","volume":"34","author":"Rawson","year":"2007","journal-title":"Oncol Nurs Forum"},{"key":"10.1111\/jth.15487_bb0190","first-page":"e1","article-title":"Prevention of central venous catheter\u2010associated thrombosis: a meta\u2010analysis","volume":"901","author":"Kirkpatrick","year":"2007","journal-title":"Am J Med"},{"issue":"3","key":"10.1111\/jth.15487_bb0195","first-page":"CD006468","article-title":"Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters","author":"Akl","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1111\/jth.15487_bb0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1160\/TH07-07-0446","article-title":"Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta\u2010analysis","volume":"99","author":"Chaukiyal","year":"2008","journal-title":"Thromb Haemost"},{"issue":"14","key":"10.1111\/jth.15487_bb0205","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMc1408861","article-title":"Anticoagulation for central venous catheters in patients with cancer","volume":"371","author":"D'Ambrosio","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1111\/jth.15487_bb0210","first-page":"CD006468","article-title":"Anticoagulation for people with cancer and central venous catheters","author":"Akl","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1111\/jth.15487_bb0215","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1200\/JCO.2012.45.5733","article-title":"Central venous catheter care for the patient with cancer: American society of clinical oncology clinical practice guideline","volume":"31","author":"Schiffer","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1111\/jth.15487_bb0220","first-page":"285","article-title":"Dynamics of thrombophlebitis in central venous catheterization via basilic and cephalic veins","volume":"150","author":"Curelaru","year":"1984","journal-title":"Acta Chir Scand"},{"issue":"6","key":"10.1111\/jth.15487_bb0225","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1308::AID-CNCR20>3.0.CO;2-3","article-title":"The timing and sequence of multiple device\u2010related complications in patients with long\u2010term indwelling Groshong catheters","volume":"78","author":"Tolar","year":"1996","journal-title":"Cancer"},{"issue":"3","key":"10.1111\/jth.15487_bb0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2003.10.003","article-title":"The prothrombotic state in cancer: pathogenic mechanisms","volume":"50","author":"De Cicco","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1111\/jth.15487_bb0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jth.12070","article-title":"International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"11","author":"Farge","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1111\/jth.15487_bb0240","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.9-5-594","article-title":"Low\u2010dose warfarin prophylaxis for catheter\u2010associated thrombosis in cancer patients. Can it be safely associated with 5\u2010Fluorouracil\u2010based chemotherapy?","volume":"9","author":"Magagnoli","year":"2004","journal-title":"Oncologist"},{"issue":"8","key":"10.1111\/jth.15487_bb0245","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1538-7836.2007.02613.x","article-title":"A pilot study of central venous catheter survival in cancer patients using low\u2010molecular\u2010weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)","volume":"5","author":"Kovacs","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15487_bb0250","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.thromres.2017.04.003","article-title":"A prospective study of rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)","volume":"162","author":"Davies","year":"2018","journal-title":"Thromb Res"},{"issue":"1","key":"10.1111\/jth.15487_bb0255","first-page":"287","article-title":"Factors influencing patient's perception of long\u2010term treatment with low\u2010molecular\u2010weight heparins for cancer\u2010associated thrombosis: an updated analysis of TROPIQUE, a prospective observational study","volume":"28","author":"Debourdeau","year":"2020","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1111\/jth.15487_bb0260","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3324\/haematol.2015.127126","article-title":"Assessing patients\u2019 anticoagulation preferences for the treatment of cancer\u2010associated thrombosis using conjoint methodology","volume":"100","author":"Noble","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"10.1111\/jth.15487_bb0265","first-page":"CD006650","article-title":"Anticoagulation for the long\u2010term treatment of venous thromboembolism in people with cancer","volume":"6","author":"Kahale","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1111\/jth.15487_bb0270","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1161\/CIRCRESAHA.116.306925","article-title":"Evolving treatments for arterial and venous thrombosis: role of the direct oral anticoagulants","volume":"118","author":"Chan","year":"2016","journal-title":"Circ Res"},{"issue":"47","key":"10.1111\/jth.15487_bb0275","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017894","article-title":"The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC\u2010related upper extremity venous thrombosis in cancer patients","volume":"98","author":"Lv","year":"2019","journal-title":"Medicine"},{"issue":"4","key":"10.1111\/jth.15487_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12517","article-title":"Canadian venous thromboembolism research, thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM\u2010Line): a two\u2010center open\u2010label pilot randomized controlled trial","volume":"5","author":"Ikesaka","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"19","key":"10.1111\/jth.15487_bb0285","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/bloodadvances.2020002637","article-title":"Safety and efficacy of anticoagulant therapy in pediatric catheter\u2010related venous thrombosis (EINSTEIN\u2010Jr CVC\u2010VTE)","volume":"4","author":"Thom","year":"2020","journal-title":"Blood Adv"},{"issue":"6","key":"10.1111\/jth.15487_bb0290","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/annonc\/mdz111","article-title":"Treatment of cancer\u2010associated venous thromboembolism in the age of direct oral anticoagulants","volume":"30","author":"Ay","year":"2019","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1111\/jth.15487_bb0295","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for thromboprophylaxis in high\u2010risk ambulatory patients with cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1111\/jth.15487_bb0300","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1111\/jth.15487_bb0305","first-page":"67","article-title":"Low\u2010molecular\u2010weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long\u2010term central venous catheters: a pilot randomized trial","volume":"88","author":"Mismetti","year":"2003","journal-title":"Haematologica"},{"issue":"7\u20138","key":"10.1111\/jth.15487_bb0310","first-page":"425","article-title":"Prospective study of thromboses of the subclavian vein after setting implantable venous access systems in cervico\u2010facial cancerology","volume":"113","author":"Bonfils","year":"1996","journal-title":"Ann Otolaryngol Chir Cervicofac"},{"issue":"3","key":"10.1111\/jth.15487_bb0315","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1148\/radiol.2203001181","article-title":"Catheter\u2010related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US","volume":"220","author":"Luciani","year":"2001","journal-title":"Radiology"},{"issue":"3","key":"10.1111\/jth.15487_bb0320","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2141.2003.04638.x","article-title":"Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler\u2010ultrasound","volume":"123","author":"van Rooden","year":"2003","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1111\/jth.15487_bb0325","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.thromres.2014.04.003","article-title":"Further data about catheter related venous thrombosis in oncology","volume":"134","author":"Marcy","year":"2014","journal-title":"Thromb Res"},{"issue":"8","key":"10.1111\/jth.15487_bb0330","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/pbc.26036","article-title":"Group, prevalence of symptomatic and asymptomatic thrombosis in pediatric oncology patients with tunneled central venous catheters","volume":"63","author":"Schoot","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1111\/jth.15487_bb0335","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.7863\/ultra.15.08019","article-title":"Peripherally inserted central catheter\u2010related upper extremity venous thrombosis in oncology patients: a prospective study based on Doppler sonography","volume":"35","author":"Luo","year":"2016","journal-title":"J Ultrasound Med"},{"issue":"11","key":"10.1111\/jth.15487_bb0340","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/cam4.1201","article-title":"Incidence, risk factors, and outcomes of central venous catheter\u2010related thromboembolism in breast cancer patients: the CAVECCAS study","volume":"6","author":"Debourdeau","year":"2017","journal-title":"Cancer Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15487","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15487","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622004767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622004767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:29:14Z","timestamp":1761535754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622004767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1538783622004767"],"URL":"https:\/\/doi.org\/10.1111\/jth.15487","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous thromboembolism associated with central venous catheters in patients with cancer: From pathophysiology to thromboprophylaxis, areas for future studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}